Is CyberArk Stock a Buy, Sell or Hold?
CyberArk Software (NASDAQ:CYBR), the identity security and management firm, has…
Sell
32
ARMP Quote, Financials, Valuation and Earnings
Last price:
$1.90
Seasonality move
:
12.71%
Day range:
$1.79 - $2.30
52-week range:
$1.79 - $4.25
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
648.50x
P/B ratio:
--
Volume:
86.5K
Avg. volume:
12.7K
1-year change:
-51.49%
Market cap:
$64.8M
Revenue:
--
EPS (TTM):
-$1.64
Earnings Data
Next earnings date for ARMP
May 07
2025
Most recent earnings per share
-$0.15
Missed by $0.15
(Nov 13/2024)
Consensus Estimate
--
(Nov 13/2024)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
ARMP Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 05/07/2025 | Q1 | $1.4M | -- | -- | -$0.38 | -- |
| 03/21/2025 | Q4 | $1.6M | -- | -- | -$0.35 | -- |
| 11/13/2024 | Q3 | $900K | -- | -$0.15 | -- | -- |
| 08/13/2024 | Q2 | $1.1M | -- | -$0.25 | -$0.36 | $0.11 |
| 05/07/2024 | Q1 | $1.1M | -- | -$0.69 | -$0.31 | -$0.38 |
| 03/21/2024 | Q4 | $860K | -- | -$0.55 | -$0.34 | -$0.21 |
| 11/14/2023 | Q3 | -- | -- | -$0.86 | -$0.31 | -$0.55 |
| 08/14/2023 | Q2 | -- | -- | -$0.17 | -$0.38 | $0.21 |
| 05/11/2023 | Q1 | -- | -- | -$0.40 | -$0.32 | -$0.08 |
| 03/17/2023 | Q4 | -- | -- | -$0.29 | -$0.28 | -$0.01 |
| 11/09/2022 | Q3 | -- | -- | -$0.24 | -$0.28 | $0.04 |
| 08/11/2022 | Q2 | -- | -- | -$0.26 | -$0.23 | -$0.03 |
| 05/12/2022 | Q1 | -- | -- | -$0.30 | -- | -- |
| 03/18/2022 | Q4 | -- | -- | -$0.23 | -- | -- |
| 11/10/2021 | Q3 | -- | -- | -$0.22 | -- | -- |
| 08/12/2021 | Q2 | -- | -- | -$0.25 | -- | -- |
| 05/13/2021 | Q1 | -- | -- | -$0.27 | -- | -- |
| 03/18/2021 | Q4 | -- | -- | -$0.36 | -- | -- |
| 11/12/2020 | Q3 | -- | -- | -$0.31 | -- | -- |
| 08/13/2020 | Q2 | -- | -- | -$0.26 | -- | -- |
| 05/14/2020 | Q1 | -- | -- | -$0.49 | -- | -- |
| 03/19/2020 | Q4 | -- | -- | -$0.48 | -- | -- |
| 11/12/2019 | Q3 | -- | -- | -$0.73 | -- | -- |
| 08/14/2019 | Q2 | -- | -- | -$0.69 | -- | -- |
| 05/06/2019 | Q1 | -- | -- | -$0.80 | -- | -- |
| 12/31/2018 | Q4 | -- | -- | $1.51 | -- | -- |
| 09/30/2018 | Q3 | -- | -- | -$0.60 | -- | -- |
| 06/30/2018 | Q2 | -- | -- | -$2.66 | -- | -- |
| 03/31/2018 | Q1 | -- | -- | -$3.36 | -- | -- |
| 12/31/2017 | Q4 | -- | -- | -$0.56 | -- | -- |
| 09/30/2017 | Q3 | -- | -- | -$1.26 | -- | -- |
| 06/30/2017 | Q2 | -- | -- | -$20.44 | -- | -- |
| 03/31/2017 | Q1 | -- | -- | -$27.16 | -- | -- |
| 12/31/2016 | Q4 | -- | -- | -$106.40 | -- | -- |
| 09/30/2016 | Q3 | -- | -- | -$45.22 | -- | -- |
| 06/30/2016 | Q2 | -- | -- | -$109.48 | -- | -- |
| 03/31/2016 | Q1 | -- | -- | -$115.08 | -- | -- |
| 12/31/2015 | Q4 | -- | -- | -$75.60 | -- | -- |
| 09/30/2015 | Q3 | -- | -- | -$42.00 | -- | -- |
| 06/30/2015 | Q2 | -- | -- | $46.20 | -- | -- |
| 03/31/2015 | Q1 | -- | -- | -$488.60 | -- | -- |
Armata Pharmaceuticals Earnings Questions
-
How Much did Armata Pharmaceuticals Generate in Revenue Last Quarter?
Armata Pharmaceuticals reported -- worth of top line sales in its most recent quarter.
-
Did Armata Pharmaceuticals Beat Earnings Last Quarter?
Armata Pharmaceuticals announced earnings per share of -$0.15 which represents a miss of analyst forecast a -- per share.
-
Is Armata Pharmaceuticals Profitable?
Armata Pharmaceuticals reported -- that represents -- per share over the last quarter.
-
What is the Analyst Consensus for Armata Pharmaceuticals EPS Next Year?
Armata Pharmaceuticals's earnings are forecast to decrease from -$1.91 per share to -$1.94 per share next year representing a decrease of -50.26%.
-
When is Armata Pharmaceuticals's Earnings Date?
Armata Pharmaceuticals's next earnings date is May 7, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Amazon Stock Still Worth Staking On?
Amazon.com Inc (NASDAQ: AMZN) posted one of its strongest years…
Is Palantir a Good Stock to Buy?
Palantir Technologies (PLTR) stock soared to its highest level in…
Stock Ideas
Buy
55
Is AAPL Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 36x
Buy
53
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Buy
51
Is NVDA Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 40x
Alerts
Sell
50
RGC alert for Mar 22
Regencell Bioscience Holdings [RGC] is up 27.82% over the past day.
Sell
36
VMI alert for Mar 22
Valmont Industries [VMI] is down 12.54% over the past day.
Buy
61
ALNY alert for Mar 22
Alnylam Pharmaceuticals [ALNY] is up 11.7% over the past day.
